| Conrad Patent applications |
| Patent application number | Title | Published |
| 20110132376 | TOPICAL ANTIVIRAL FORMULATIONS - The present invention relates to formulations of nucleotide reverse transcriptase inhibitors (NRTIs), preferably [2-(6-Amino-purin-9-yl)-1-methyl-ethoxymethyl]-phosphonic acid (tenofovir, PMPA), or a physiologically functional derivative thereof, suitable for topical application and their use in the prevention of HIV infections. | 06-09-2011 |
| 20110120475 | TOPICAL ANTIVIRAL FORMULATIONS - The present invention relates to formulations of nucleotide reverse transcriptase inhibitors (NRTIs), preferably [2-(6-Amino-purin-9-yl)-1-methyl-ethoxymethyl]-phosphonic acid (tenofovir, PMPA), or a physiologically functional derivative thereof, suitable for topical application and their use in the prevention of HIV infections. | 05-26-2011 |